Jindal Medical Store Pharmaceutical Export Profile — India (DGFT 2022–2026)

Name: Jindal Medical Store Pharmaceutical Export Portfolio Dataset — 2 Products, $2.9K FOB USD, India (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Jindal Medical Store — Pharmaceutical Exporter Profile (2026) | 2 Products, $2.9K Trade | TransData Nexus

Jindal Medical Store

Indian Pharmaceutical Exporter · Brand Names & OTC Products Specialist · $2.9K Total Trade · DGFT Verified

Jindal Medical Store is an Indian pharmaceutical exporter with a total trade value of $2.9K across 2 products in 1 therapeutic categories. Based on 7 verified export shipments from Indian Customs (DGFT) records, the company actively competes across multiple product segments. Top exports include Crocin ($1.9K), Combiflam ($1.0K), .

Jindal Medical Store — Export Portfolio & Destination Treemap

Jindal Medical Store pharmaceutical export portfolio — 2 products across 1 therapeutic categories. Source: Indian Customs (DGFT).

Who is Jindal Medical Store? — Company Overview & Market Position

Established in 1968, Jindal Medical Store (JMS) is a prominent Indian pharmaceutical exporter headquartered in New Delhi, India. The company operates as a proprietorship under the leadership of Mr. Vijay Kumar Jindal, with Mr. Kapil Jindal serving as the Director. JMS specializes in the export and distribution of finished pharmaceutical formulations, including tablets, capsules, syrups, and injections. The company has a workforce of approximately 26 to 50 employees and reported an annual turnover between ₹25 crore and ₹100 crore. JMS holds an Import Export Code (IEC) of 0506005640 and a Goods and Services Tax (GST) number of 07AAGPJ6138E1ZV.

Over the decades, JMS has expanded its global footprint, exporting to countries such as China, Hong Kong, the United States, Ethiopia, Italy, the United Kingdom, Kuwait, Nepal, Turkey, Australia, Georgia, the Philippines, France, Canada, Germany, and Portugal. The company's product portfolio includes over 735 items, with a significant focus on erectile dysfunction medications, anti-cancer drugs, and anti-HIV treatments.

What Does Jindal Medical Store Export? — Product Portfolio Analysis

Top Products by Export Value

1Crocin$1.9K

Product Portfolio — Top 2 by Export Value

Jindal Medical Store exports 2 pharmaceutical products across 1 therapeutic categories.

#	Product	Category	Export Value	Shipments	Market Share	Rank
1	Crocin	Brand Names & OTC Products	$1.9K	4	2.2%	6
2	Combiflam	Brand Names & OTC Products	$1.0K	3	4.2%	6

Jindal Medical Store exports 2 pharmaceutical products across 1 therapeutic categories with a total export value of $2.9K. The top category is Brand Names & OTC Products (100.0% of portfolio), indicating a concentrated portfolio with the top 5 products accounting for 100.0% of total export value.

Jindal Medical Store — Corporate Profile & Information

Headquarters, ownership, manufacturing facilities, and key leadership

1Corporate Overview

2Manufacturing Facilities

JMS operates dedicated manufacturing units under the names Prime Life Science and Prime Ayurveda. These facilities specialize in the production of allopathic, Ayurvedic, and anti-cancer drugs, catering to both domestic and international markets. The company emphasizes maintaining a substantial inventory with fresh manufacturing and long shelf life to meet global demand.

3Key Leadership

The leadership of Jindal Medical Store is spearheaded by Mr. Vijay Kumar Jindal, the founder, whose vision and strategic direction have been instrumental in the company's growth since its inception in 1968. Mr. Kapil Jindal serves as the Director, continuing the legacy of the Jindal family in the pharmaceutical export sector. The company's management team comprises professionals dedicated to upholding JMS's commitment to quality, customer service, and ethical business practices.

TransData Nexus Research · Government registries, company filings, regulatory databasesMar 2026

Where Does Jindal Medical Store Export? — Destination Intelligence

Regulated market presence, emerging market penetration, and geographic strategy

1Regulated Markets

Jindal Medical Store has established a presence in several regulated markets, including the United States, European Union, United Kingdom, Australia, and Japan. The company has engaged in exports to these regions, indicating compliance with international standards and regulations. While specific regulatory filings and approvals are not publicly disclosed, JMS's longstanding operations and partnerships suggest adherence to the requisite regulatory frameworks of these markets. The company's focus on quality assurance and ethical business practices further supports its ability to navigate and comply with the stringent requirements of these regulated markets.

2Emerging Markets

JMS has expanded its reach into emerging markets across Africa, Latin America, and Southeast Asia. The company's export activities in these regions are facilitated by its adherence to international quality standards, as evidenced by certifications such as ISO 9001:2008. These certifications enhance JMS's credibility and facilitate access to markets that prioritize quality compliance. The company's strategic focus on these emerging markets aligns with its mission to provide quality healthcare solutions globally.

3Geographic Strategy

Jindal Medical Store — Manufacturing & Regulatory Profile

FDA status, WHO-GMP certification, EU GMP compliance, and regulatory track record

1FDA Status

Specific details regarding Jindal Medical Store's FDA facility registrations, approved Abbreviated New Drug Applications (ANDAs), Drug Master File (DMF) filings, and inspection history are not publicly available. However, the company's extensive export activities to regulated markets such as the United States suggest compliance with FDA regulations. JMS's adherence to international quality standards, including ISO 9001:2008 certification, further supports its capability to meet FDA requirements. The company's longstanding operations and partnerships indicate a commitment to maintaining high-quality manufacturing practices.

2WHO & EU GMP

Jindal Medical Store's commitment to quality is evidenced by its ISO 9001:2008 certification, which underscores the company's adherence to international quality management standards. While specific certifications such as WHO prequalification and EU Good Manufacturing Practice (GMP) certificates are not publicly disclosed, the company's export activities to various international markets suggest compliance with these standards. The focus on quality assurance and ethical business practices positions JMS as a reliable partner in the global pharmaceutical supply chain.

CDSCO & Indian Regulatory

Jindal Medical Store — Competitive Positioning Among Indian Pharma Exporters

Market share comparison, key differentiators, and strategic analysis

1Competitive Landscape

Jindal Medical Store operates in a competitive landscape with several key players in the pharmaceutical export sector. While specific market share data is not publicly available, JMS's extensive product portfolio, including over 735 items, and its export activities to 17 countries indicate a significant presence in the market. The company's focus on quality assurance, customer service, and ethical business practices differentiates it from competitors. Strategic partnerships with major pharmaceutical companies such as Pfizer, Novartis, Wyeth, Abbott, and Cipla further enhance JMS's competitive position.

2Key Differentiators

Jindal Medical Store's key differentiators include its extensive product portfolio, comprising over 735 items, and its specialization in erectile dysfunction medications, anti-cancer drugs, and anti-HIV treatments. The company's commitment to quality is evidenced by its ISO 9001:2008 certification, and its focus on customer service is reflected in its 24/7 customer support. JMS's ethical business practices, transparency, and professionalism further distinguish it in the pharmaceutical export sector.

3Strategic Position

Buyer Due Diligence Brief — Evaluating Jindal Medical Store as a Supplier

Track record assessment, certifications to verify, and pre-order checks

1Supplier Assessment

Jindal Medical Store has a track record of consistent export volume, with a total export value of $3,000 USD across seven shipments, indicating reliability in fulfilling international orders. The company's focus on quality assurance, evidenced by its ISO 9001:2008 certification, and its commitment to customer service, as reflected in its 24/7 support, further enhance its reliability as a supplier. JMS's ethical business practices and transparency contribute to its reputation as a trustworthy partner in the pharmaceutical export sector.

2Certifications to Verify

Importers should verify the following certifications when considering Jindal Medical Store as a supplier:

ISO 9001:2008 Certification: This certification indicates adherence to international quality management standards. Verification can be done by requesting a copy of the certificate from JMS or checking with the certifying body.

WHO-GMP Certification: This certification confirms compliance with World Health Organization Good Manufacturing Practices. Verification can be done by contacting the World Health Organization or the relevant national regulatory authority.

Frequently Asked Questions — Jindal Medical Store

How many pharmaceutical products does Jindal Medical Store export from India?

Jindal Medical Store exports 2 pharmaceutical products across 1 therapeutic categories. The top exports are Crocin ($1.9K), Combiflam ($1.0K). Total export value is $2.9K.

What is Jindal Medical Store's total pharmaceutical export value?

Jindal Medical Store's total pharmaceutical export value is $2.9K, based on 7 verified shipments recorded in Indian Customs (DGFT) data.

What therapeutic categories does Jindal Medical Store cover?

Jindal Medical Store exports across 1 therapeutic categories. The largest are Brand Names & OTC Products (100.0%, 2 products).

Get Full Jindal Medical Store Export Intelligence

Access shipment-level details, pricing data, buyer connections, product breakdown, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify manufacturer licensing, GMP certification, and export registration with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports per product category. For current shipment-level data, contact TransData Nexus.